Chevalier, Bernard2; Dimario, Carlo3; Neumann, Franz-Josef3; Cutlip, Donald E3; Williams, David O3; Ormiston, John3; Grube, Eberhard3; Whitbourn, Robert3; Coe, Jessie3; Schwartz, Lewis B3; Saunamäki, Kari1
1 Hjertemedicinsk Klinik, Hjertecentret Rigshospitalet, Rigshospitalet, The Capital Region of Denmark2 Institut Cardio-vasculaire, Paris-Sud, Massy, France.3 unknown
five-year results from the ZOMAXX I trial
The ZOMAXX I trial tested the noninferiority of a zotarolimus-eluting coronary stent (ZoMaxx(™) ) when compared with a paclitaxel-eluting coronary stent (Taxus(™) Express(2™) ) in a randomized trial of percutaneous intervention for de novo coronary artery stenosis. Angiographic analysis at the primary endpoint of 9 months has been reported previously. The purpose of this follow-on analysis was to describe the clinical results of the ZoMaxx and Taxus cohorts of the ZOMAXX I trial after 5 years.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography and Interventions, 2013, Vol 82, Issue 7, p. 1039-47